Toxicity of Doxorubicin (Dox) to different experimental organ systems

被引:437
作者
Arivalagan Pugazhendhi [1 ]
Edison, Thomas Nesakumar Jebakumar Immanuel [2 ]
Velmurugan, Bharath Kumar [3 ]
Jacob, Joe Antony [4 ]
Karuppusamy, Indira [5 ]
机构
[1] Ton Duc Thang Univ, Fac Environm & Labour Safety, Innovat Green Prod Synth & Renewable Environm Dev, Ho Chi Minh City, Vietnam
[2] Yeungnam Univ, Sch Chem Engn, Gyongsan 38541, Gyeongbuk, South Korea
[3] China Med Univ Hosp, Environm Omics Dis Res Ctr, Taichung, Taiwan
[4] Southeast Univ, Sch Med, Zhongda Hosp, Dept Hematol & Oncol, Nanjing, Jiangsu, Peoples R China
[5] Indira Gandhi Ctr Atom Res, Corros Sci & Technol Div, Kalpakkam 603102, Tamil Nadu, India
关键词
Doxorubicin; Mechanism; Toxicity; Multi-organ; Oxidative stress; PEGYLATED LIPOSOMAL DOXORUBICIN; INDUCED CARDIOTOXICITY; OXIDATIVE STRESS; MEDIATED APOPTOSIS; RADIATION RECALL; OVARIAN-CANCER; IN-VITRO; RATS; NANOPARTICLES; CELLS;
D O I
10.1016/j.lfs.2018.03.023
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
Doxorubicin (Dox) is a valuable anticancer drug for hematologic and solid tumors. Yet, it can cause multi-organ toxicities in various patients. Since toxicity evaluation is a major criterion to discuss for every experiment, the current mini-review focuses on the toxicity of Dox to multiple organs and suggests the most probable mechanism. Though several mechanisms have been suggested, the role of oxidative stress remains elusive among other mechanisms and remains the most probable mechanism for cardiotoxic effect of Dox.
引用
收藏
页码:26 / 30
页数:5
相关论文
共 49 条
[1]
Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes [J].
Altieri, Paola ;
Barisione, Chiara ;
Lazzarini, Edoardo ;
Garuti, Anna ;
Bezante, Gian Paolo ;
Canepa, Marco ;
Spallarossa, Paolo ;
Tocchetti, Carlo Gabriele ;
Bollini, Sveva ;
Brunelli, Claudio ;
Ameri, Pietro .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (01)
[2]
[Anonymous], 2017, PLOS ONE
[3]
Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis [J].
Barlesi, Fabrice ;
Tummino, Celine ;
Tasei, Anne-Marie ;
Astoul, Philippe .
LUNG CANCER, 2006, 54 (03) :423-425
[4]
Barros GP, 2012, INT J GEOPHYS, V2012, DOI [10.1155/2012/459497, 10.5402/2012/137289]
[5]
Bendale Y, 2017, INTEGR MED RES, V6, P141, DOI [10.1016/j.imr.2017.01.006, 10.1016/j.imr.2017.01.006|]
[6]
A comparison of replicative senescence and doxorubicin-induced premature senescence of vascular smooth muscle cells isolated from human aorta [J].
Bielak-Zmijewska, Anna ;
Wnuk, Maciej ;
Przybylska, Dorota ;
Grabowska, Wioleta ;
Lewinska, Anna ;
Alster, Olga ;
Korwek, Zbigniew ;
Cmoch, Anna ;
Myszka, Aleksander ;
Pikula, Slawomir ;
Mosieniak, Grazyna ;
Sikora, Ewa .
BIOGERONTOLOGY, 2014, 15 (01) :47-64
[7]
Radiation Recall with Anticancer Agents [J].
Burris, Howard A., III ;
Hurtig, Jane .
ONCOLOGIST, 2010, 15 (11) :1227-1237
[8]
A herbal formula, SYKT, reverses doxorubicin-induced myelosuppression and cardiotoxicity by inhibiting ROS-mediated apoptosis [J].
Chen, Ting ;
Shen, Hong-Mei ;
Deng, Zhi-Yong ;
Yang, Zuo-Zhang ;
Zhao, Rui-Lian ;
Wang, Li ;
Feng, Zhi-Ping ;
Liu, Chao ;
Li, Wen-Hui ;
Liu, Zhi-Jie .
MOLECULAR MEDICINE REPORTS, 2017, 15 (04) :2057-2066
[9]
Protective effect of berberine on doxorubicin-induced acute hepatorenal toxicity in rats [J].
Chen, Xueyan ;
Zhang, Yu ;
Zhu, Zhongning ;
Liu, Huanlong ;
Guo, Huicai ;
Xiong, Chen ;
Xie, Kerang ;
Zhang, Xiaofei ;
Su, Suwen .
MOLECULAR MEDICINE REPORTS, 2016, 13 (05) :3953-3960
[10]
Doxorubicin coupled to lactosaminated albumin: Effects on rats with liver fibrosis and cirrhosis [J].
Di Stefano, G. ;
Fiume, L. ;
Domenicali, M. ;
Busi, C. ;
Chieco, P. ;
Kratz, F. ;
Lanza, M. ;
Mattioli, A. ;
Pariali, M. ;
Bernardi, M. .
DIGESTIVE AND LIVER DISEASE, 2006, 38 (06) :404-408